BioCardia Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy BioCardia Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioCardia Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioCardia Inc. is BCDA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioCardia Inc. has its primary listing on NASDAQ (Small cap). You can trade BioCardia Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioCardia Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioCardia Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioCardia Inc..